CARER Collaborates with WHOLELEAF to Enhance Holistic Cancer Care Services
Bangalore : CARER, India’s first Integrative Oncology company that provides holistic cancer care to patients, is pleased to announce its collaboration with Wholeleaf, a licensed medical cannabis and CBD company. This collaboration aims to further improve the quality of life of patients undergoing cancer treatment by offering products that can be seamlessly integrated into CARER’s nutrition, physical therapy, and mental well-being services.
CARER is India’s first Integrative Oncology solution, offering evidence-based non-clinical therapies that complement mainstream cancer treatments. CARER’s therapies work in conjunction with conventional treatment methods such as surgery, chemotherapy, and radiation to improve a patient’s outcomes, nutritionally, physically and psychologically.
Wholeleaf is the first licensed medical cannabis and CBD brand in India that is focussed on chronic and neuropathic pain management. Their GMP manufactured , lab tested , proprietary formulations contain medical cannabis leaf extract infused with ayurvedic super-herbs that provide a safe and effective way to relieve pain. Wholeleaf is licensed by the Ayush ministry to legally manufacture and distribute their formulations pan India.
A recent report published by the British Medical Journal indicates that medicinal cannabis can safely alleviate cancer pain and mitigate the associated side effects of treatment. The study found that the use of medicinal cannabis significantly reduced pain intensity, suggesting it as a safe and complementary treatment option for providing adequate pain relief.
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being. CARER’s primary focus is to enhance patients’ quality of life, improve treatment adherence, and effectively manage treatment-related side effects. Through their service-based structure, CARER provides personalized interventions in nutrition, physical therapy, and mental well-being. By collaborating with Wholeleaf, CARER aims to amplify the impact of their services by offering products that improve patients’ quality of life and alleviate pain and side effects of cancer treatment based on the treating physician’s consent.
Commenting on the collaboration, Samara Mahindra, CEO and Founder of CARER, said, “Having extensively researched medical cannabis for managing cancer pain, CARER is familiar with its benefits. We have closely tracked Wholeleaf’s journey and the extensive research conducted by them to curate and formulate the right products. Some of our patients have already had the opportunity to try Wholeleaf’s products and have personally experienced their benefits.”
“This collaboration with Wholeleaf aligns with our mission to further improve the quality of life of our patients, alleviate treatment side effects, and holistically support them during their cancer journey. The products developed by Wholeleaf have the potential to significantly enhance quality of life and reduce treatment-related side effects. We have always sought partnerships with products and companies that contribute to the well-being of our patients. This collaboration with Wholeleaf is a step in that direction”, Samara added.
Shivraj Sharma, CEO and Founder, Wholeleaf, said, “Cannabinoids found in medical cannabis are powerful natural compounds that have been clinically validated globally, offering a wide range of medical benefits without harsh long term adverse effects. These products are particularly useful for pain management. We are excited to collaborate with CARER in improving the quality of life for cancer patients. CARER has been at the forefront of creating an impactful holistic care model for cancer patients, and their services have transformed the lives of many. We are delighted to support their mission by integrating the CARER Protocol with our products. We look forward to a fruitful partnership.”
In addition to pain management, Wholeleaf’s products also address other significant side effects such as sleep issues, anxiety, nausea, and fatigue, which are commonly faced by cancer patients. By complementing CARER’s existing services, Wholeleaf’s products act as an additional element, amplifying the impact of their services and the overall benefits to CARER’s patients.